Teva Pharma (TEVA): Estimates Fall On Actavis - RBC

July 12, 2016 6:35 AM EDT Send to a Friend
RBC Capital analyst, Randall Stanicky, believes the AGN generics closing has dragged on longer than expected, and with closing imminent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login